Skip to main content
. 2021 Feb 11;27:100726. doi: 10.1016/j.ymgmr.2021.100726

Table 2.

Mutational spectrum in non-PMM2 patients.

Diagnosis Variant Status
ALG13-CDG
(X-linked)
c.320A > G,
p.Asn107Ser,
de novo
Heterozygous
c.280A > G, p.Lys94Glu,
de novo
Hemizygous
ALG1-CDG (AR) c.773C > T,
p.Ser258Leu
Heterozygous
c.1182C > G,
p.Phe394Leu
Heterozygous
MPI-CDG (AR) c.1193 T > C,
p. Ile398Thr
Homozygous (siblings)
c.656G > A,
p.Arg219Glu
Heterozygous
c.748G > A,
p.Gly250Ser
Heterozygous
PGM1-CDG (AR) c.988G > C,
p.Gly330Arg
Heterozygous
c.1129G > A,
p.Glu377Lys
Heterozygous
SRD5A3-CDG (AR) c.292_293del,
p.Leu98ValfsX121
Homozygous (siblings)
c.424C > T,
p.Arg142X
Homozygous or heterozygous
c.489C > A,
p.Tyr163Ter
Heterozygous
DPAGT1-CDG (AR) c.1117C > G,
p. Pro373Ala
Heterozygous
c.1197 T > A,
p.Tyr399X
Heterozygous
ATP6AP1-CDG (X-linked) c.1284G > A,
p.Met428Ile
Homozygous (siblings)
ATP6V0A2-CDG (AR) c.2015 T > A,
p.Leu672X
Heterozygous
c.130delG,
p.N43fsX55
Heterozygous
VMA21-CDG
(X-linked)
c.188A > G,
p.Asn63Gly
Heterozygous